Semaglutide vs Tirzepatide: Comparison Table MechanismAvg Weight Loss %Dosage FrequencyHormones TargetedSingle agonist13.7% to 14.9%Weekly injectionGLP-1Dual agonist20.2% to 20.9%Weekly injectionGLP-1 and GIP What 2026 clinical data reveals about efficacy and weight loss averages The most comprehensive data comparing these two medications comes from direct, head to head clinical trials
You may also opt to pick up certain medications at a local pharmacy if preferred
Critical Research Limitations These findings, while encouraging, come with significant caveats: Very small sample sizes (typically fewer than 10 mother-infant pairs) Short observation periods (no multi-year developmental follow-up) No data on younger infants (most studies involved babies over 4 months old) Unknown long-term effects on infant metabolism, pancreatic function, or growth patterns As the National Institutes of Health's LactMed database notes, while semaglutide was not detectable in milk samples, "the long-term effects of infant exposure are unknown." Beyond Direct Transfer: Indirect Effects on Breastfeeding Even if Ozempic doesn't transfer significantly into breast milk, it can affect breastfeeding through other mechanisms that are particularly important for Australian mothers to understand
For example, Smoothie King has added a GLP-1 Support Menu (Fantozzi, 2024)
Wound-healing biology: re-epithelialization, angiogenesis, granulation-tissue quality (model-dependent)